NCORP Cancer Trials Activated - March 2019
Posted: March 22, 2019
The cancer studies below were approved recently and are open to enroll participants through the NCI Community Oncology Research Program (NCORP). NCORP is a national network that brings cancer clinical trials and cancer care delivery studies to people in their local communities.
For more information, click on the link in the title. All open NCORP studies are listed at: Find a Study.
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting (EAQ161CD) was activated Jan. 8, 2019. Lead Research Base: ECOG-ACRIN. Summary: assess current biomarker testing practices for common solid cancers in precision oncology in the community setting.
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer (NRG CC003), which had been temporarily closed Oct. 13, 2017, after completing the phase II portion, was re-activated Jan. 9, 2019. Lead Research Base: NRG. Summary: randomized phase II/III trial studies how well whole-brain radiation therapy works and compares it with or without hippocampal avoidance in treating patients with small cell lung cancer that is found in one lung, the tissues between the lungs, and nearby lymph nodes only (limited stage) or has spread outside of the lung in which it began or to other parts of the body (extensive stage).
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients with Cancer (A221701) was activated Feb. 15. Lead Research Base: Alliance. Summary: this phase III trial studies how well dexamethasone works in reducing everolimus-induced oral stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced oral stomatitis so as to improve quality of life in cancer patients.
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery (S1600) was activated Feb. 15. Lead Research Base: Southwest Oncology Group. Summary: This randomized phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.